《Medicalxpress,1月12日,Researchers use artificial intelligence to guide the search for the next SARS-like virus》

  • 来源专题:COVID-19科研动态监测
  • 编译者: YUTING
  • 发布时间:2022-01-25
  • Vaccination offers long-lasting protection from the worst outcomes of COVID-19, according to a new study by the University of North Carolina at Chapel Hill.

    The emergence of the delta and omicron variants has raised questions about whether breakthrough infections are caused by waning immunity or by the more transmissible variants.

    Results of the study published in the New England Journal of Medicine suggest that declining immunity is responsible for breakthrough infections, but vaccines maintained protection from hospitalization and severe disease nine months after getting the first shot.

    "The primary takeaway message from our study is that unvaccinated people should get vaccinated right away," said lead study author Danyu Lin, Ph.D., Dennis Gillings Distinguished Professor of Biostatistics at the UNC Gillings School of Global Public Health. "The results of our study also underscore the importance of booster shots, especially for older adults."

    The study, which is a collaboration between the UNC-Chapel Hill and the North Carolina Department of Health and Human Services, examined data on COVID-19 vaccination history and health outcomes for 10.6 million North Carolina residents between December 2020 and September 2021.

  • 原文来源:https://medicalxpress.com/news/2022-01-covid-vaccines.html
相关报告
  • 《Medicalxpress,1月19日,Researchers use artificial intelligence to guide the search for the next SARS-like virus》

    • 来源专题:COVID-19科研动态监测
    • 编译者:YUTING
    • 发布时间:2022-02-09
    • A research team led by Professor Hongzhe Sun, Norman & Cecilia Yip Professor in Bioinorganic Chemistry from the Department of Chemistry, Faculty of Science, the University of Hong Kong (HKU), in collaboration with Dr. Shuofeng Yuan, Assistant Professor from the Department of Microbiology, Li Ka Shing Faculty of Medicine, discovered that orally administrated bismuth drug colloidal bismuth subcitrate (CBS) together with N-acetyl cysteine (NAC) could be a broad-spectrum anti-coronavirus cocktail therapy. Oral administration of the cocktail suppresses the replication cycle of the virus, reduces viral loads in the lung and ameliorates virus-induced pneumonia in a hamster infection model. Not only could NAC stabilize bismuth-containing metallodrugs at stomach-like conditions but also enhance the uptake of bismuth drugs in tissues (e.g. lung) and antiviral potency through oral administration. Bismuth subsequently suppressed virus replication of a panel of clinically relevant coronaviruses, including Middle East respiratory syndrome-related coronavirus (MERS-CoV), Human coronavirus 229E (hCoV-229E) and Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its alpha variant (B.1.1.7) by inactivating multiple essential viral enzymes. The findings provided insights into the development of inorganic pharmaceutics and a new therapeutic approach for viral infections. The ground-breaking findings have been published in the journal, Chemical Science and a related patent has been filed in the US.
  • 《Medicalxpress,1月10日,Researchers use artificial intelligence to guide the search for the next SARS-like virus》

    • 来源专题:COVID-19科研动态监测
    • 编译者:YUTING
    • 发布时间:2022-01-17
    • An international research team led by scientists at Georgetown University have demonstrated the power of artificial intelligence to predict which viruses could infect humans like SARS-CoV-2, the virus that led to the COVID-19 pandemic which animals host them, and where they could emerge.